Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer.

Oncotarget · 2017 · PMC5362509 · PMID 28121628

Europe PMC DOI

hedged sentences

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significancep=0.055so close (0.05 < p ≤ 0.1)

For OS, an adjusted HR of 0.72 was observed, with a borderline significance (95% CI 0.52-1.01, p=0.055).

also in 4,964 other papers

borderline significantno p-value reported

In the entire cohort, FAS was identified as significant prognostic marker for recurrence (adjusted HR 0.53, 95% CI 0.36-0.77) and borderline significant marker for overall survival (adjusted HR 0.72, 95% CI 0.52-1.01).

also in 7,848 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.